Ottmann v. Hanger Orthopedic Group, Inc.

United States Court of Appeals for the Fourth Circuit · 2003 · Corporations

Updated August 22, 2026

CorporationsSecurities fraudPleading standardsScienterSection 10(b)Rule 10b-5PSLRArecklessness

Facts

After Hanger acquired NovaCare, Hanger reported third-quarter 1999 results and discussed the integration in a November 8, 1999 press release and conference call. Appellants alleged that Hanger and its officers misstated the number and reasons for departing NovaCare practitioners and failed to disclose NovaCare's different revenue-recognition practice and a decline in referral business from rehabilitation clinics. On January 6 and 7, 2000, Hanger announced disappointing results and explained that practitioner departures, revenue-recognition conformity, and reduced referrals had hurt revenue and earnings. Hanger's stock price then fell sharply, and investors claimed the earlier statements and omissions were fraudulent.

Issue

Whether the complaint pleaded with sufficient particularity that defendants made materially false or misleading statements or omissions and, especially, facts giving rise to a strong inference of scienter as required by the PSLRA. Also, whether recklessness may satisfy the scienter requirement in a Section 10(b) and Rule 10b-5 action.

Rule

To state a Section 10(b) and Rule 10b-5 claim, a plaintiff must allege a false statement or omission of material fact, scienter, justifiable reliance, and proximate causation. Under the PSLRA, the complaint must specify each misleading statement, why it is misleading, and plead with particularity facts giving rise to a strong inference that the defendant acted with the required state of mind. Scienter includes intentional misconduct and recklessness, with recklessness defined as an act so highly unreasonable and such an extreme departure from ordinary care as to present a danger of misleading investors that was either known to the defendant or so obvious that the defendant must have been aware of it. In assessing scienter, courts should use a flexible, case-specific analysis of all allegations collectively rather than limiting themselves to formal categories such as motive and opportunity.

See the holding & full analysis

Create a free KwikCourt account to unlock the rest of this brief — and practice the case.

The court's holding and reasoning
Doctrine tests, pitfalls & exam hypotheticals
10 practice questions + 4 AI-graded essays on this case

Free sample · practice this case

Test yourself

One of 10 multiple-choice questions for this case. Pick an answer to see why.

Summit Vision Clinics, a publicly traded company based in Denver, acquires a regional chain and says on an earnings call that "about 12" acquired optometrists left after closing. Two months later, Summit discloses that 21 had actually left, but it had already told investors the departures caused $6 million in lost quarterly revenue. Shareholders sue, alleging fraud but pleading no insider sales, no personal benefit, and no facts showing executives ignored obvious warning signs during the integration.

Under the governing scienter standard, which is the strongest argument for dismissing the complaint?

Explanation. Scienter under Section 10(b) and Rule 10b-5 may be shown by intent or recklessness, but recklessness requires conduct that is highly unreasonable and an extreme departure from ordinary care, with a danger of misleading investors that was known or so obvious the defendant must have been aware of it. A rough approximation later shown to be wrong, coupled with disclosed revenue impact, no personal motive, and no pleaded red flags, supports only negligence rather than the PSLRA's required strong inference of scienter. Generalized motives are insufficient. (Derived from Ottmann v. Hanger Orthopedic Group, Inc. (n.d.).)